Literature DB >> 15021060

Pathogenesis of hypersensitivity pneumonitis.

Melissa Girard1, Evelyne Israël-Assayag, Yvon Cormier.   

Abstract

PURPOSE OF REVIEW: Hypersensitivity pneumonitis is a group of immunologically mediated diseases caused by an abnormal response to a wide variety of inhaled antigens. Its pathogenesis is complex and involves many immunological concepts. This review discusses recent advances in our understanding of the pathogenesis of hypersensitivity pneumonitis. RECENT
FINDINGS: Over the last 3 years, several studies on the pathogenesis of hypersensitivity pneumonitis have been published. New antigens have been identified. We now have a better understanding of the role of inflammatory cells and mediators, and promoting and protective factors have been suggested.
SUMMARY: Most of the mechanisms involved in the pathogenesis of hypersensitivity pneumonitis remain incompletely understood. Current and future findings will not only help our understanding of the disease and its prevention, but also improve its treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15021060     DOI: 10.1097/00130832-200404000-00004

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  15 in total

1.  Pesticides and other agricultural factors associated with self-reported farmer's lung among farm residents in the Agricultural Health Study.

Authors:  Jane A Hoppin; David M Umbach; Greg J Kullman; Paul K Henneberger; Stephanie J London; Michael C R Alavanja; Dale P Sandler
Journal:  Occup Environ Med       Date:  2006-12-20       Impact factor: 4.402

2.  A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung.

Authors:  C A Huppé; P Blais Lecours; A Lechasseur; D R Gendron; A M Lemay; E Y Bissonnette; M R Blanchet; C Duchaine; M C Morissette; H Rosen; D Marsolais
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

3.  Stachybotrys chartarum-induced hypersensitivity pneumonitis is TLR9 dependent.

Authors:  Urvashi Bhan; Michael J Newstead; Xianying Zeng; Megan N Ballinger; Louis R Standiford; Theodore J Standiford
Journal:  Am J Pathol       Date:  2011-10-05       Impact factor: 4.307

4.  CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis.

Authors:  Marie-Renée Blanchet; Jami L Bennett; Matthew J Gold; Elena Levantini; Daniel G Tenen; Melissa Girard; Yvon Cormier; Kelly M McNagny
Journal:  Am J Respir Crit Care Med       Date:  2011-06-03       Impact factor: 21.405

5.  Metalworking fluid with mycobacteria and endotoxin induces hypersensitivity pneumonitis in mice.

Authors:  Peter S Thorne; Andrea Adamcakova-Dodd; Kevin M Kelly; Marsha E O'neill; Caroline Duchaine
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

6.  Fcgamma receptors modulate pulmonary inflammation by activating innate immune cells in murine hypersensitivity pneumonitis.

Authors:  Hyo Jin Park; Hye Sung Kim; Doo Hyun Chung
Journal:  Immune Netw       Date:  2010-02-28       Impact factor: 6.303

7.  Significance of Foxp3+CD4+ regulatory T cells in the peripheral blood of Uygur patients in the acute and chronic phases of pigeon breeder's lung.

Authors:  Biqing Yu; Xiaohong Yang; Fengsen Li; Chao Wu; Wenyi Wang; Wei Ding
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

Review 8.  Cigarette smoking and diffuse lung disease.

Authors:  Rajesh R Patel; Jay H Ryu; Robert Vassallo
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Rituximab-induced hypersensitivity pneumonitis.

Authors:  Adriano R Tonelli; Richard Lottenberg; Robert W Allan; P S Sriram
Journal:  Respiration       Date:  2008-10-09       Impact factor: 3.580

10.  A critical role of Dectin-1 in hypersensitivity pneumonitis.

Authors:  Mari Higashino-Kameda; Toshiki Yabe-Wada; Shintaro Matsuba; Kazuya Takeda; Kazushi Anzawa; Takashi Mochizuki; Koichi Makimura; Shinobu Saijo; Yoichiro Iwakura; Hirohisa Toga; Akira Nakamura
Journal:  Inflamm Res       Date:  2015-12-07       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.